Bridgepoint Education, Inc. (NYSE: BPI) $16.73. Bridgepoint announced Wednesday that its academic institution, Ashford University, has been granted initial accreditation for five years by the Accrediting Commission for Senior Colleges and Universities of the Western Association of Schools and Colleges (WASC). Barrington Research upgraded the stock to Outperform this morning.
Celgene Corp. (Nasdaq: CELG) $136.36. Celgene announced that its phase III study (MM-020/IFM 07-01) of REVLIMID (lenalidomide) in combination with dexamethasone in patients newly diagnosed with multiple myeloma met its primary endpoint of progression-free survival (PFS). For more color on the achievement, click here.
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) $44.65. Alnylam Pharma reported positive top-line results from its ongoing Phase I trial of ALN-TTRsc, a subcutaneously administered RNAi therapeutic targeting the transthyretin (TTR) gene for the treatment of TTR-mediated amyloidosis (ATTR). The company is reporting that ALN-TTRsc achieved robust and statistically significant (p0.01) knockdown of serum TTR protein levels of greater than 80% in healthy volunteer subjects, in line with results for ALN-TTRsc previously reported in non-human primates. br / Hertz (NYSE: HTZ) $27.04. Hertz received approval from the U.S. FTC over a slightly modified settlement in the $2.3 billion acquisition of Dollar Thrifty Automotive Group, Inc. Click here for more color. Amarin Corp Plc (Nasdaq: AMRN) $5.30. Amarin priced a 24,955,000 offering at $5.60 per ADS. Another 3,255,000 ADSs is issuable to the Underwriters pursuant to a 30-day option.
Alvarion Ltd. (Nasdaq: ALVR) $0.50. Alvarion announced today that Silicon Valley Bank has submitted today a request to the District Court of Tel-Aviv – Yaffo for the enforcement of liens registered in connection with a Loan granted by SVB to the company, and for the appointment of a Receiver to enforce such Liens. The company is reviewing the legal ramifications of this request. Shares were halved on the news.